Premier Alternatives

Tenpoint Therapeutics

London, United Kingdom · Founded 2019 · Privately Held (backing)

Operator of a biotechnology platform intended to restore vision for people with degenerative ocular diseases. Tenpoint Therapeutics is based in London, United Kingdom and was founded in 2019. Its last reported valuation was $76.6 million in Jul 2023. It has raised $312 million.

Last reported valuation
$76.6M
Oct 2026
Priced at
—
Total raised
$312.1M
Last round
—

Tenpoint Therapeutics key facts

as of Oct 2026
  • Operator of a biotechnology platform intended to restore vision for people with degenerative ocular diseases.
  • Tenpoint Therapeutics is valued at approximately $76.6M as of Oct 2026 (last reported valuation).
  • It has raised $312.1M; the latest was Later Stage VC ($235.0M) in Jan 2026.
  • Notable investors include F-Prime Capital, Qiming Venture Partners USA, Eight Roads, British Business Bank, Hillhouse Investment Group — 15 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$76.6M

Tenpoint Therapeutics's last reported valuation, Jul 2023. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Tenpoint Therapeutics with a free account
  • ·The complete investor list: 15 names
  • ·Watch Tenpoint Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Tenpoint Therapeutics funding rounds

No rounds on record

No funding rounds for Tenpoint Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Tenpoint Therapeutics valuation

Tenpoint Therapeutics's last reported valuation was $76.6 million in Jul 2023. No priced round, secondary trade or fund mark has surfaced since.

Tenpoint Therapeutics investors

15 investors are on record for Tenpoint Therapeutics, including F-Prime Capital, Qiming Venture Partners USA, Eight Roads and British Business Bank. By type, the record holds 4 venture capital firms and 1 family office.

About Tenpoint Therapeutics

Operator of a biotechnology platform intended to restore vision for people with degenerative ocular diseases. The company's platform offers engineered cell-based therapies and in vivo reprogramming and has a focus on developing systems that can be delivered directly to the eye, bypassing the need for systemic administration, enabling healthcare providers to make a significant impact on the lives of patients with eye diseases.

Sector
Healthcare
HQ
London, United Kingdom
Founded
2019
Employees
78
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.